Search

Zai Lab Ltd ADR

Nyitva

SzektorEgészségügy

24.08 0.21

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

23.96

Maximum

24.64

Fő mutatók

By Trading Economics

Bevétel

191K

-51M

Értékesítés

6.7M

106M

Egy részvényre jutó nyereség

-0.46

Profit margin

-47.808

Munkavállalók

1,784

EBITDA

-2.1M

-46M

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 5.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

892M

2.9B

Előző nyitás

23.87

Előző zárás

24.08

Hangulat hírek alapján

By Acuity

38%

62%

106 / 339 Rangsor szerint Healthcare

Zai Lab Ltd ADR Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. szept. 10. 23:51 UTC

News

The Nikkei 225 Index is lower in after-market hours, pressured by rising oil prices above $100 and a recent European Central Bank rate hike.

2026. szept. 10. 23:46 UTC

Correlated Moves
News

Valero Energy Corp is trading higher in after-market hours following a Power Inflow alert, reflecting increased buying interest among investors.

2026. szept. 10. 23:41 UTC

Event
News

AbbVie Inc declared a quarterly dividend of $1.73, with a record date of October 15, 2026. Shares are higher in after-hours trading.

2026. szept. 10. 23:31 UTC

Correlated Moves
Macro Event
News

The USD/THB exchange rate is gaining during Thursday's session, supported by recent macroeconomic data, despite a lack of typical volatility in the market.

2026. szept. 10. 23:26 UTC

News

Constellation Brands will report second-quarter results on October 6. In after-market trading, shares are higher, though still near the lower end of their one-month range.

2026. szept. 10. 23:16 UTC

News

Artisan Partners Asset Management reports $183.5 billion in AUM as of August 31. Shares are trading lower in after-market hours following a client restructuring.

2026. szept. 10. 23:16 UTC

News

Accenture PLC secured a $480.37 million Army contract for the Joint Enterprise Task Management System, boosting shares in after-market trading.

2026. szept. 10. 23:16 UTC

News

Tencent Music Entertainment closed a $1 billion notes offering, with shares trading higher in after-market hours. Proceeds will support corporate purposes and debt refinancing.

2026. szept. 10. 23:11 UTC

Correlated Moves
News
Macro Event

The USD/SGD exchange rate is trading higher amid recent macroeconomic data, including a rise in the US Producer Price Index and Initial Jobless Claims.

2026. szept. 10. 23:06 UTC

News
Social Media

Microsoft plans to expand data center capacity to over 38 gigawatts by 2032. Shares are lower in after-market trading, continuing recent declines.

2026. szept. 10. 23:06 UTC

News

Wedbush initiated coverage on Datadog with an Outperform rating and a $275 price target. Shares are higher in after-market trading, closing at $225.27.

2026. szept. 10. 23:06 UTC

News

HP Inc. shares are higher in after-market trading following RBC Capital's initiation of coverage with a Sector Perform rating and a $33.00 price target.

2026. szept. 10. 23:06 UTC

Correlated Moves
News
Macro Event

The USD/ZAR exchange rate is higher today, supported by US Producer Price Index data and Initial Jobless Claims that indicate labor market resilience.

2026. szept. 10. 23:06 UTC

Correlated Moves
News

Autodesk has entered an agreement for $1 billion in senior notes to refinance debt. Shares are trading higher in after-market hours following the announcement.

2026. szept. 10. 23:02 UTC

News

Visa Inc shares are lower in after-market hours, despite launching an onchain lending initiative with Credit Coop that financed $2.5 billion.

2026. szept. 10. 23:02 UTC

News
Social Media

GameStop Corp shares rose in after-hours trading following CEO Ryan Cohen's purchase of 1 million shares for about $20.4 million, boosting his ownership stake.

2026. szept. 10. 23:02 UTC

News
Event
Social Media

Oracle Corp reported Q1 earnings of $1.92, exceeding estimates, and raised its fiscal 2027 EPS guidance to $8.10. Shares rose in after-hours trading.

2026. szept. 10. 23:02 UTC

News
Social Media

Adobe shares declined in after-market trading following Q3 results. While revenue of $6.76 billion surpassed expectations, fourth-quarter guidance fell short of consensus.

2026. szept. 10. 23:01 UTC

Social Media
News

ACV Auctions shares rise sharply in after-hours trading on reports of Copart's nearing $1.9 billion acquisition deal at $10.50 per share.

2026. szept. 10. 23:01 UTC

Correlated Moves
News
Macro Event

The USD/HUF exchange rate is higher, supported by recent macroeconomic data and a correlated rise in USD/CHF. Earlier, it peaked with a notable gain.

2026. szept. 10. 23:01 UTC

Event
Social Media
News

RH shares rose in after-market trading after reporting fiscal Q2 results, including adjusted EPS of $2.70, significantly surpassing estimates of $1.78.

2026. szept. 10. 23:01 UTC

Correlated Moves
News
Macro Event

The USD/SEK exchange rate is rising, supported by US PPI data and jobless claims indicating a resilient labor market. The pair remains above its 20-day moving average.

2026. szept. 10. 23:01 UTC

Correlated Moves
News

Comfort Systems USA Inc. is higher in after-market trading, reflecting strong five-year performance with a market cap of $55.99 billion. IES Holdings Inc. also rose.

2026. szept. 10. 23:01 UTC

Correlated Moves
News
Social Media

Robinhood Markets Inc shares declined in after-market trading following mixed August operating data, including a drop in net deposits and securities lending revenue.

2026. szept. 10. 23:01 UTC

News
Social Media

Celsius Holdings shares rose in after-hours trading after CEO John Fieldly bought 18,000 shares for $493.8K, boosting his total ownership to 956,000 shares.

2026. szept. 10. 23:01 UTC

Correlated Moves
News
Macro Event

The USD/NOK exchange rate is rising, supported by positive US PPI data and resilient jobless claims figures. Broader market trends also favor the currency pair.

2026. szept. 10. 23:01 UTC

News
Social Media

Copart Inc will acquire ACV Auctions for $10.50 per share, valuing the deal at $1.9 billion. Shares rose significantly in after-market trading.

2026. szept. 10. 22:51 UTC

News

Wix.Com Ltd shares are lower in after-market hours following a class action lawsuit alleging false statements about its AI product offerings and financial disclosures.

2026. szept. 10. 22:46 UTC

News

Curtiss-Wright Corp lowers shares in after-market hours despite announcing a $700 million share repurchase authorization and a quarterly dividend of $0.26 per share.

2026. szept. 10. 22:41 UTC

News

Thor Industries shares rise sharply in after-market trading following leadership changes aimed at restructuring North American RV operations to enhance efficiency and cost savings.

Társak összehasonlítása

Árváltozás

Zai Lab Ltd ADR Előrejelzés

Értékelési konszenzus

By TipRanks

Erős vétel

3 ratings

3

Vétel

0

Tartás

0

Eladás

Hangulat

By Acuity

106 / 339 Rangsor szerint Egészségügy

Hangulat hírek alapján

Bullish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat